NCT05483998View on ClinicalTrials.gov

A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 9, 2022

Primary Completion Date

April 13, 2023

Study Completion Date

June 18, 2023

Conditions
Healthy Subjects
Interventions
DRUG

TLC-2716

TLC-2716

OTHER

Placebo

Placebo to match

Trial Locations (1)

Unknown

OrsoBio Research Site, Auckland

Sponsors

Lead Sponsor

OrsoBio, Inc
All Listed Sponsors
lead

OrsoBio, Inc

INDUSTRY

NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants | Biotech Hunter | Biotech Hunter